Literature DB >> 20665707

Role of PPARγ in the salutary effects of 17β-estradiol on Kupffer cell cytokine production following trauma-hemorrhage.

Takao Suzuki1, Takashi Kawasaki, Mashkoor A Choudhry, Irshad H Chaudry.   

Abstract

Studies have shown that administration of 17β-estradiol prevents trauma-hemorrhage-induced increase in proinflammatory cytokine production by Kupffer cells and associated multiple organ injury. Since activation of peroxisome proliferator-activated receptor γ (PPARγ) following ischemic conditions has been shown to be protective, we examined if PPARγ plays any role in the salutary effects of 17β-estradiol on Kupffer cell cytokine production following trauma-hemorrhage. Male mice underwent trauma-hemorrhage (mean blood pressure 40 mmHg for 90 min, then resuscitation). 17β-estradiol (50 µg/kg) or vehicle with or without PPARγ antagonist GW9662 was injected subcutaneously at the middle of resuscitation. At 2 h after trauma-hemorrhage, plasma interleukin (IL)-6 and tumor necrosis factor (TNF)-α levels, Kupffer cell IL-6 and TNF-α production and mRNA expression, and PPARγ, nuclear factor (NF)-κB and activator protein (AP)-1 DNA binding activity were determined. Kupffer cell IL-6 and TNF-α production, as well as plasma IL-6 and TNF-α levels, increased following trauma-hemorrhage. Moreover, NF-κB and AP-1 DNA binding activity and IL-6 and TNF-α mRNA expression were also enhanced under such conditions. However, 17β-estradiol administration normalized all these parameters. Although PPARγ activity decreased after trauma-hemorrhage, administration of 17β-estradiol following trauma-hemorrhage elevated PPARγ activity above the normal level. Inhibition of PPARγ by co-administration of GW9662, however, abolished the salutary effects of 17β-estradiol on plasma cytokine and Kupffer cells. Thus, activation of PPARγ appears to play an important role in mediating the salutary effects of 17β-estradiol on plasma cytokine levels and Kupffer cell cytokine production after trauma-hemorrhage, which are likely mediated via NF-κB and AP-1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20665707     DOI: 10.1002/jcp.22327

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

Review 1.  Trauma equals danger--damage control by the immune system.

Authors:  Veit M Stoecklein; Akinori Osuka; James A Lederer
Journal:  J Leukoc Biol       Date:  2012-05-31       Impact factor: 4.962

Review 2.  Experimental trauma models: an update.

Authors:  Michael Frink; Hagen Andruszkow; Christian Zeckey; Christian Krettek; Frank Hildebrand
Journal:  J Biomed Biotechnol       Date:  2011-01-26

3.  Maraviroc attenuates trauma-hemorrhage-induced hepatic injury through PPAR gamma-dependent pathway in rats.

Authors:  Fu-Chao Liu; Yung-Fong Tsai; Huang-Ping Yu
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

4.  Maraviroc-Mediated Lung Protection following Trauma-Hemorrhagic Shock.

Authors:  Fu-Chao Liu; Chih-Wen Zheng; Huang-Ping Yu
Journal:  Biomed Res Int       Date:  2016-07-31       Impact factor: 3.411

Review 5.  Maraviroc: a review of its use in HIV infection and beyond.

Authors:  Shawna M Woollard; Georgette D Kanmogne
Journal:  Drug Des Devel Ther       Date:  2015-10-01       Impact factor: 4.162

6.  The Effect of Blood Loss in the Presence and Absence of Severe Soft Tissue Injury on Hemodynamic and Metabolic Parameters; an Experimental study.

Authors:  Ali Mohammad Moradi; Omid Aj; Shahram Paydar; Farzaneh Ketabchi; Seyed Mostafa Sheid Moosavi; Shahram Bolandparvaz; Hamid Reza Abassi; Aryan Dokht Tamadon; Davood Mehrabani
Journal:  Emerg (Tehran)       Date:  2015
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.